Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allegra “Drives On” With Physician Campaign Ahead Of Claritin OTC Switch

Executive Summary

Aventis will not change its marketing strategy for Allegra following the departure of Schering-Plough's Claritin from the prescription antihistamine market

You may also be interested in...



Allegra Ads Cited For Superiority Claims; Zyrtec Data Stronger, FDA Says

FDA is challenging Aventis' TV and print advertisements for Allegra on the grounds that they imply the product is superior to other antihistamines, FDA's ad division said

Allegra Ads Cited For Superiority Claims; Zyrtec Data Stronger, FDA Says

FDA is challenging Aventis' TV and print advertisements for Allegra on the grounds that they imply the product is superior to other antihistamines, FDA's ad division said

Formularies Should Stress Rx Compliance, Not Co-Pays, Pitney Bowes Says

Covering chronic disease medications as tier one to encourage patient compliance can help manage health care costs, Pitney Bowes Manager-Employee Benefits Design & Development Christine Berman said

Related Content

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel